Is there occult tissue ischemia in chronic end-stage liver disease?
β Scribed by Parker, Brian M. ;Dishart, Michael K. ;Pinsky, Michael R. ;Kang, Yoogoo
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1999
- Tongue
- English
- Weight
- 74 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1074-3022
No coin nor oath required. For personal study only.
β¦ Synopsis
Whether pathological oxygen supply dependency exists in patients with chronic end-stage liver disease (CESLD) is unknown, although the frequently occurring multiorgan dysfunction seen in these patients may be the result of occult tissue ischemia. In this study, 15 adult patients with CESLD were evaluated for the presence of pathological oxygen supply dependency and, thus, occult tissue ischemia before undergoing orthotopic liver transplantation. Whole-body oxygen consumption (VO 2 ) was measured using indirect calorimetry at baseline, at reduced oxygen deliv-ery (DO 2 ) using positive end-expiratory pressure, and at increased DO 2 using volume infusion. As a group, no significant increase or decrease in VO 2 was observed with changes in DO 2 . However, 4 patients showed increases in VO 2 of 14%, 10.8%, 9.6%, and 8.2% when DO 2 was increased. The study results suggest that pathological oxygen supply dependency is present in a subset of patients with CESLD, and the existence of occult tissue ischemia is speculated.
π SIMILAR VOLUMES
Our aim was to evaluate gastric emptying and orocecal transit in patients with end-stage liver disease and portal hypertension undergoing evaluation for liver transplantation. Although gastric emptying half-times for both liquid and solid emptying were similar in patients with chronic liver disease
End-stage liver disease (ESLD) has become the main cause of mortality in patients coinfected by human immunodeficiency virus (HIV) and hepatitis B virus or hepatitis C virus in developed countries. The aim of this study was to describe the natural history of and prognostic factors for ESLD, with par
Despite improved survival after liver transplantation (OLTX) in HIV-positive individuals treated with highly active antiretroviral therapy (HAART), some transplant candidates do not survive to OLTX. To determine if pretransplant outcome is related to severity of liver disease and/or HIV infection, w